Arabian Ethicals
Arabian Ethicals is a UAE-based healthcare distributor (founded 1977, Ghobash Group subsidiary) that distributes pharmaceuticals, consumer health, and veterinary products to 2,000+ government and private healthcare clients across all seven Emirates, operating validated cold-chain warehousing and a 17-vehicle temperature-monitored fleet.
- Company typePrivate
- Founded1977
- HeadquartersDuba, Saudi Arabia
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Arabian Ethicals does
Arabian Ethicals is a UAE-based healthcare distribution company founded in 1977 and operating as an enterprise under Ghobash Group, a diversified UAE conglomerate. The company runs three core divisions — Pharmaceuticals, Consumer Health, and Veterinary Medicine — providing end-to-end services spanning regulatory registration, importation, warehousing, market access, government tender participation, promotion, sales, and distribution. It serves more than 2,000 clients across UAE government healthcare institutions, private hospitals and clinics, retail pharmacy networks, modern trade retailers, and veterinary clinics, and extends selected distribution services into GCC markets.
The company operates 5,700 square meters of climate-controlled warehousing at Dubai Silicon Oasis with additional capacity in Al Quoz and a regional office in Abu Dhabi. Its technology stack is built around validated cold-chain infrastructure: a 17-vehicle GPS-tracked and continuously temperature-monitored distribution fleet, automated inventory management systems, and product serialization/traceability systems designed for biologics, vaccines, and insulin. The platform is certified to GDP, GMP, ISO 9001, ISO 31000:2018, and MOCCAE standards, and is registered with MOHAP.
Revenue is generated through transaction-fee distribution margins on branded and generic pharmaceuticals, consumer health products, and veterinary pharmaceuticals sourced from multinational principals including Accord Healthcare, NUK, Himalaya, Acino Pharma, and others. A dedicated medical promotion team of qualified representatives drives field sales to enterprise and government buyers. Pricing is negotiated through multi-year partnership agreements rather than publicly disclosed. The company is recognized by IQVIA as a Top 10 pharmaceutical distributor in UAE (2024).
Arabian Ethicals firmographics
Firmographics- Name
- Arabian Ethicals
- Legal name
- Arabian Ethicals Company
- Website
- https://arabianethicals.ae
- Company type
- Private
- Founded year
- 1977
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Arabian Ethicals is a UAE-based healthcare distributor (founded 1977, Ghobash Group subsidiary) that distributes pharmaceuticals, consumer health, and veterinary products to 2,000+ government and private healthcare clients across all seven Emirates, operating validated cold-chain warehousing and a 17-vehicle temperature-monitored fleet.
- Ownership category
- akta.pro rank
Arabian Ethicals industry classification
Industry- Product category
- Pharmaceutical Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Veterinary Distributor Value-Added Services (3PL, Cold Chain, Returns) (HLAMAIAG)
- akta.pro secondary industries
- Veterinary Pharmaceutical Wholesalers & Distributors (HLAMAIAA), Pet Pharmaceuticals & Veterinary Supply Distribution (CRAOAKAD)
Keywords
Where Arabian Ethicals is headquartered
LocationHeadquarters
- HQ city
- Duba
- HQ country
- Saudi Arabia
- HQ region
- Middle East
Offices4 records
Markets served
Arabian Ethicals business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D
Revenue model
- Pharmaceutical Distribution: Distribution of branded and generic pharmaceuticals to hospitals, pharmacies, medical centers and clinics across UAE. Revenue derived from margin on product sales through authorized distribution agreements with global pharmaceutical manufacturers.
- Consumer Health Distribution: Distribution of consumer health products including baby care, foot care, skincare and wellness products through modern trade channels, retail, specialty shops and pharmacies.
- Veterinary Products Distribution: Distribution of veterinary pharmaceuticals, vaccines, and nutritional supplements for livestock and pets to veterinary clinics and farms across UAE.
- Market Access Services: Registration, market access, government affairs and tender services supporting pharmaceutical brand entry into UAE market.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | B2B Distribution Partnership Pricing |
Go-to-market motion3 records
Distribution channels6 records
Marketing channels8 records
Arabian Ethicals product offering
Product offeringCore offering
Arabian Ethicals distributes pharmaceuticals, consumer health products, and veterinary medicines across the UAE through three dedicated divisions. Services span the full value chain including product registration, importation, GDP/GMP-compliant warehousing, market access, government affairs and tender management, sales, promotion, and nationwide distribution to hospitals, pharmacies, clinics, modern trade retailers, and veterinary facilities.
Product overview
Arabian Ethicals is a healthcare distribution company operating three core divisions: Pharmaceuticals, Consumer Health, and Veterinary Medicine. The company provides end-to-end distribution services including registration, importation, warehousing, market access, and sales to healthcare providers across the UAE. Its pharmaceutical division distributes branded and generic medicines and oncology treatments including the Accord Healthcare portfolio. The consumer health division distributes baby care brands (NUK), wellness products (Himalaya, Acino Pharma), and skincare products through retail and pharmacy channels. The veterinary division supplies animal health products, vaccines, and pharmaceuticals for livestock and companion animals. The company also offers cold-chain logistics capabilities for temperature-sensitive products including biologics, vaccines, and insulin.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceuticals Distribution End-to-end pharmaceutical distribution services including registration, importation, warehousing, market access, government affairs and tenders, promotion, sales and distribution to hospitals, pharmacies, medical centres and private clinics throughout the UAE.
- Consumer Health Distribution Distribution of consumer health products including baby care, foot care, skincare, and wellness products through modern trade channels, retail, specialty shops and pharmacies, with logistics and creative sales and marketing support.
- Veterinary Medicine Distribution Distribution of veterinary pharmaceuticals, vaccines, antibiotics, nutritional supplements and medical devices for livestock and companion animals across the UAE, with cold-chain support and MOCCAE-compliant operations.
- Cold-Chain Distribution Services Validated cold-chain logistics infrastructure with temperature monitoring, product serialization, and traceability for temperature-sensitive therapies including biologics, vaccines, and insulin, delivered through a 17-vehicle GPS-tracked calibrated fleet.
- Market Access Services Registration, market access strategy development, government affairs, tender management, and regulatory compliance services that enable pharmaceutical market entry into the UAE.
Quantifiable outcome
- Top 10 pharmaceutical distributor in UAE (IQVIA 2024)
- +2 more outcomes
Companies that use Arabian Ethicals
Customer profileNamed customers5 records
Segments6 records
Ideal customer profiles5 records
Arabian Ethicals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Arabian Ethicals partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core, primary and minor.
- Accord HealthcarecoreStrategic partnership to enhance availability and accessibility of essential cancer therapies and critical oncology treatments for patients across the UAE. The collaboration combines Arabian Ethicals' strong UAE presence and market-access capabilities with Accord Healthcare's extensive global portfolio including 37 oncology-related treatments. Partnership enables introduction of upcoming biosimilars and novel therapies from Accord's global pipeline.
- Ghobash GroupcoreArabian Ethicals is a Ghobash Group enterprise, a progressive and diversified UAE-based business conglomerate. The company leverages the group's infrastructure, resources, and brand promise of 'Growth for Good' to deliver healthcare solutions.
- Acino PharmaprimaryConsumer health distribution partnership for wellness and healthcare products in UAE market
- HimalayaprimaryConsumer health distribution partnership for trusted health and wellness brands in UAE
- NUKprimaryExclusive distribution of NUK baby care products including the Perfect Match line in UAE market. Arabian Ethicals represented NUK at Baby Expo 2025 for brand awareness and consumer engagement.
- Global Multinational Pharmaceutical BrandsprimaryLong-standing partnerships with global multinational pharmaceutical brands covering branded and generic medicines, specialty drugs, and hospital-grade pharmaceuticals for UAE market distribution.
- Companies for GoodminorCSR collaboration for the Toys for Hope initiative, helping businesses create positive social impact through meaningful community activities.
- Ghobash Group MarketingminorInternal collaboration for CSR activities and marketing initiatives including Toys for Hope CSR event.
Scale indicators8 records
Recent moves7 records
Expansion highlights5 records
Arabian Ethicals competitors and assessment
Company assessmentBroad incumbents
- Julphar (Gulf Pharmaceutical Industries): UAE-headquartered pharmaceutical manufacturer and distributor with manufacturing operations and a broad MENA distribution footprint. Comparable because it operates a vertically integrated pharma business with significant UAE distribution exposure and competes for the same hospital and pharmacy customers as Arabian Ethicals.
- Hikma Pharmaceuticals: Jordan-headquartered multinational pharmaceutical company with significant MENA manufacturing and distribution operations. Comparable as a broader incumbent competing in branded generics, injectables, and biosimilars across the same regional hospital and pharmacy channels.
Direct peers
- Pharmatrade LLC: UAE-based pharmaceutical and healthcare distributor serving hospitals, clinics, and pharmacies. Direct peer because it operates the same third-party distribution model targeting the same UAE healthcare customer base with similar multinational brand portfolios.
- Al Ittihad Drug Store (IDS): Established UAE pharmaceutical wholesaler and distributor with a multi-decade history serving government and private healthcare institutions. Comparable because of similar product mix (branded and generic pharma), similar customer base, and similar reliance on multinational brand partnerships.
- LifePharma FZE: UAE-based pharmaceutical distribution company with a focus on branded and specialty pharmaceuticals across MENA markets. Direct peer given overlapping product portfolio, similar regulatory positioning with MOHAP, and competition for the same principal brand partnerships.
- Abu Dhabi National Pharmaceuticals (ADNP): UAE-based pharmaceutical distributor serving Abu Dhabi and northern emirates government healthcare institutions. Direct peer given overlapping UAE government tender participation, similar branded/generic portfolio, and comparable regulatory positioning with MOHAP and DOH.
Regional players
- SPIMACO Addwaeih: Saudi Arabia-based pharmaceutical manufacturer and distributor with MENA-wide distribution. Comparable as a regional player with similar pharma distribution capabilities, GCC regulatory expertise, and multinational brand partnerships, though primarily Saudi-focused.
- Tabuk Pharmaceuticals: Saudi-headquartered pharmaceutical manufacturer with growing distribution across the GCC. Comparable because it competes for the same multinational brand distribution mandates and serves overlapping government hospital and pharmacy customers, though anchored in Saudi Arabia.
Emerging players
- BinSina Pharmacy: UAE pharmacy chain that increasingly pursues direct procurement relationships with manufacturers. Comparable because it is both a downstream customer of Arabian Ethicals today and a potential disintermediation risk if it scales its direct sourcing capabilities.
- Vetoquinol / Zoetis (MENA veterinary distribution arms): Global animal health majors that distribute veterinary pharmaceuticals, vaccines, and nutritional supplements across MENA, including UAE. Comparable to Arabian Ethicals' veterinary division given overlapping product categories (vaccines, antibiotics, supplements) and similar customer base of veterinary clinics and farms.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Arabian Ethicals social profiles
Digital presenceArabian Ethicals compliance and trust
Trust signalCompliance7 records
Arabian Ethicals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Arabian Ethicals leadership team
Management profileNumber of profiles
Profiles4 records
Arabian Ethicals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Arabian Ethicals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Arabian Ethicals
What does Arabian Ethicals do?
Arabian Ethicals distributes pharmaceuticals, consumer health products, and veterinary medicines across the UAE through three dedicated divisions. Services span the full value chain including product registration, importation, GDP/GMP-compliant warehousing, market access, government affairs and tender management, sales, promotion, and nationwide distribution to hospitals, pharmacies, clinics, modern trade retailers, and veterinary facilities.
Is Arabian Ethicals a public or private company?
Arabian Ethicals is a private company. It is classified as corporate owned and is currently operating.
When was Arabian Ethicals founded?
Arabian Ethicals was founded in 1977. It employs 101 to 250 people.
Where is Arabian Ethicals based?
Arabian Ethicals is headquartered in Duba, Saudi Arabia, in the Middle East region.
How does Arabian Ethicals make money?
Four revenue lines are on record. Pharmaceutical Distribution is the primary driver. The others are consumer Health Distribution, veterinary Products Distribution and market Access Services.
Who are Arabian Ethicals's main competitors?
Broad incumbents on record are Julphar (Gulf Pharmaceutical Industries) and Hikma Pharmaceuticals. Direct peers are Pharmatrade LLC, Al Ittihad Drug Store (IDS), LifePharma FZE and Abu Dhabi National Pharmaceuticals (ADNP). Regional players are SPIMACO Addwaeih and Tabuk Pharmaceuticals. Emerging players are BinSina Pharmacy and Vetoquinol / Zoetis (MENA veterinary distribution arms).
Does Arabian Ethicals have an API?
No public API is recorded for Arabian Ethicals.
What industry is Arabian Ethicals in?
Arabian Ethicals's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is HLAMAIAG, Veterinary Distributor Value-Added Services (3PL, Cold Chain, Returns), with a secondary code of HLAMAIAA, Veterinary Pharmaceutical Wholesalers & Distributors. Its NAICS code is 42421 and its SIC code is 5122.